Skip to main content

Obstetrics/Gynecology

RSS  

Articles

  • C-Reactive Protein Hits the Big Time

    Elevated CRP levels are associated with inducible ischemia in patients with stable coronary disease, particularly among those not treated with beta-blockers or statins.
  • Clinical Briefs

    Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients; Combination Treatment of Angiotensin-II Receptor Blocker and Angiotensin-Converting-Enzyme Inhibitor in Non-Diabetic Renal Disease (COOPERATE): A Randomized Controlled Trial; Early Onset of Action and Efficacy of a Combination of Calcipotriene and Betamethasone Dipropionate in the Treatment of Psoriasis
  • ECG Review: Chest Pain in a 21 Year Old

    Clinical Scenario: The ECG in the Figure shows normal sinus rhythm at a rate of 80 beats/minute. The PR, QRS, and QT intervals are normal. There is an rSR pattern in lead III. The axis is +40°. There is no sign of chamber enlargement. The most remarkable finding on this tracing is the presence of subtle but real ST segment elevation in multiple leads including I, II, aVF, and V2 through V6.
  • Pharmacology Watch: Smallpox Vaccination Guidelines Published by CDC

    Smallpox Vaccination Guidelines Published by CDC; Nurses: Delay Vaccination Program; Viagra Effective for Depression Treatment; Finisteride/Doxazosin no Better than Placebo for Urinary Obstruction; Serevent Receives Dear Doctor Letter
  • Moderation In All Things, Even Sleep

    Women who habitually sleep 5 or fewer or 9 or more hours per night have an increased risk of coronary heart disease compared with those who sleep 7 or 8 hours a night.
  • Pharmacology Update: Alefacept (Amevive) for Psoriasis Treatment

    Alefacept is a new biological agent for the treatment of moderate-to-severe plaque psoriasis. The drug, which targets T lymphocytes, is a fusion protein combining the binding site of lymphocyte function-associated antigen-3 and the Fc portion of human IgG1.
  • Full March 15, 2003 Issue in PDF

  • Maintain confidential care for adolescents

    Your practice includes confidential care for adolescents, including provision of contraceptives and testing/treatment for sexually transmitted diseases (STDs). But are your office staff communicating the confidentiality of this information correctly to prospective teen patients? If they are not, adolescents may fail to access these important services.
  • The Pill and bone health: What is the impact?

    Combined oral contraceptives (OCs) help decrease a womans risk for epithelial ovarian cancer and endometrial cancer, reduce her risk of pelvic inflammatory disease and ectopic pregnancy, and lessen menstrual cramps and pain. But what is their impact on bone mineral density (BMD)?
  • Ask the Experts: Answers to questions on OC use, DMPA impact

    Whats the impact of concomitant medications on combined oral contraceptives (OCs)?